Publicacións en colaboración con investigadores/as de Universidad de Navarra (49)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

2021

  1. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

    Chest, Vol. 160, Núm. 3, pp. 872-878

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  3. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  4. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

2020

  1. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  2. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  2. Plasma metabolomics and clinical predictors of survival differences in COPD patients

    Respiratory Research, Vol. 20, Núm. 1

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort

    PLoS ONE, Vol. 13, Núm. 2

  3. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

  4. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1

  5. Pulmonary arterial enlargement predicts long-term survival in COPD patients

    PLoS ONE, Vol. 13, Núm. 4

  6. Temporal transitions in COPD severity stages within the GOLD 2017 classification system

    Respiratory Medicine, Vol. 142, pp. 81-85

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 53, Núm. 10, pp. 574-582

  3. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  4. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients

    Respiratory Research, Vol. 18, Núm. 1